DARK SECRETS: 15 - The Real Truth

A strange star with a solid surface

The unique neutron star 4U 0142+61 has a solid surface and a giant ring of matter orbiting it

Salon · Jan 9, 2023

Losing weight doesn't resolve inflammation tied to weight gain, mouse study suggests

In a mouse study published Thursday in the journal Science, researchers found that inflammation lingered in mice that had been fed a high-fat diet after the rodents shed the ounces.

Inverse · Jan 5, 2023

At least half the world’s glaciers could disappear — and that’s under the best-case scenario

Researchers find that up to half of glaciers will disappear by the end of the century, but even more could be lost under higher global warming scenarios.

Inverse · Jan 5, 2023

India-wide subscription to research journals paves path for Global South

With rising fees for research journals, India is pressing ahead with a nation-wide subscription to allow more people to access science.

360info · Dec 20, 2022

Commentary: Eating animals got us into this mess. Going vegan will get us out

Are you ready for another lockdown? We may be headed that way. According to a recent study published in the journal Science Advances, increasing animal agriculture elevates the risk of zoonotic diseases, which are animal-borne and transmissible to humans, like COVID-19. So let’s do our part to thwart future pandemics…

Tribune News Service · Dec 20, 2022

A Law That Facilitates Cannabis Research Exemplifies the Modesty of the Reforms We Can Expect From Congress

Making it easier for scientists to study marijuana is a far cry from the liberalization that most Americans want.

Reason · Dec 7, 2022

Experimental Alzheimer's drug shows promise – but there are many hurdles still to overcome

The first drug that can slow the rate of decline in Alzheimer’s patients has been found. The experimental drug, called lecanemab, is an antibody that targets the toxic clumps of amyloid protein associated with the mind-robbing disease. While these results are cause for celebration, there are still significant questions about…

The Conversation · Dec 1, 2022

Safety concerns hang over new Alzheimer's treatment

Two deaths linked to the drug may present a more complicated path to approval.

Axios · Nov 29, 2022

A groundbreaking finding on multiple sclerosis is dividing scientists

A recent study has provided some of the strongest evidence so far that the Epstein-Barr virus and MS are linked, but scientists point to other possible causes.

Inverse · Nov 26, 2022

‘Breakthrough’ new universal flu vaccine may be ready by 2024, scientists say`

The study was published in the Science journal

Evening Standard · Nov 25, 2022